Build your career on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
Eurofins BioPharma Product Testing Leiden B.V., part of the globally operating Eurofins Scientific network, is a leading GMP-certified contract laboratory serving the (bio)pharmaceutical industry. Based at the Leiden Bio Science Park, we provide a comprehensive range of microbiological, viral, chemical, and physical quality control testing for pharmaceutical raw materials, intermediates, and finished products. In addition to our standard test packages, we develop and validate product-specific methods in close collaboration with our clients, and we also offer small-scale manufacturing services.
We have a professional team consisting of a mix of young and experienced people with different backgrounds and experiences. Together we strengthen global healthcare and help advance pharmaceutical product quality and patient safety worldwide.
As Molecular Biology Analyst, you will be responsible for carrying out a wide range of test methods on various biopharmaceutical products. You work in close collaboration with your team of Molecular Analysts, and also other departments, such as Study Management and QA. The work is performed in accordance with strict quality standards and protocols, including Good Manufacturing Practices (GMP).
Your key responsibilities include:
This role offers the opportunity to contribute to the safety and quality of pharmaceutical products within a close-knit team where collegiality and collaboration come first.
We offer a responsible and challenging position within the team with room for your own ideas and input.
Eurofins Scientific is een internationaal beursgenoteerd life sciences organisatie dat klanten voorziet van laboratoriumonderzoek en advies. Eurofins is met 61.000 collega's globaal marktleider in bio-analytische testen voor food & feed, water, milieu, farmacie en agro en maakt daarbij gebruik van 200.000+ unieke analysemethoden. Eurofins bestaat wereldwijd uit 900 hypermoderne labs met een pro-forma omzet van €6.7 miljard en heeft ruim 61 acquisities gedaan in 2022 in verschillende landen.
View what's on offer:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.